@surftohealth88 The funny thing is that in Canada, they priced Orgovyx exactly the same as Firmagon (about US $215/month) and comparably to Lupron on a month-by-month basis, so it shouldn't make a difference to the provincial health ministries or private insurers. The only reason to keep prescribing the older, injectable ADTs are

1. A patient with dementia who might not remember to take a daily pill.
2. A patient who (for some reason) might react badly to GnRH antagonists.
3. Lack of awareness of the availability of Orgovyx as an alternative (it became widely available here only in 2024).